VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Search All
Search All
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Close Filter
Find report
Search
09/20/2023
IMP - Disclosure: Regarding the record date and confirmation of the list of Securities owners.
09/15/2023
IMP - Resolution of the BOD No.9/2023/NQ-HĐQT-IMP dated September 15, 2023
09/15/2023
IMP: No 442/IMP on 15/09/2023 Re. the record date to excercise the right to receive dividends od 2023 byt cash and stocks
09/15/2023
IMP: No. 440 on 15/09/2023 - Notice issuance of shares to pay dividends
09/12/2023
IMP - Disclosure: official dispatch of the SSC re. receipt of full documents reporting on stock issuance to pay dividends in 2022 of IMP
08/15/2023
IMP: Resolution of the BOD No. 08/2023/NQ-HĐQT-IMP dated August 14, 2023
08/15/2023
IMP - Resolution of the BOD No. 07/2023/NQ-HĐQT-IMP dated August 14, 2023
08/09/2023
IMP: Reviewed Interim Financial Statements for the 6 months period end 30 June 2023
07/28/2023
IMP: Report on Corporate Governance for the First 6 months of 2023
07/25/2023
IMP - IR Newsletter Q2 2023
«
‹
1
2
3
4
5
6
7
8
9
10
›
»